Links for 2007-01-30: Durect EpiCept License
Durect EpiCept License Agreement of December 20, 2006
exclusive worldwide license for a transdermal patch containing bupivacaine for the treatment of back pain. $1.0 million payment and up to an additional $9.0 million in milestones, plus royalties
exclusive worldwide license for a transdermal patch containing bupivacaine for the treatment of back pain. $1.0 million payment and up to an additional $9.0 million in milestones, plus royalties


0 Comments:
Post a Comment
Links to this post:
Create a Link
<< Home